SCHEMBL2232333

SCHEMBL2232333

Cc1ccc(C(=O)C2=C(O)C(=O)N(CC(C)O)C2c2ccc(C(C)(C)C)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ANXA2 P07355 14/20 0.66
S100A10 P60903 14/20 0.66
ALDH1A1 P00352 2/20 0.48
MAPT P10636 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
CCR1 P32246 1/20 0.44
MEN1 O00255 1/20 0.42
ALOX15 P16050 1/20 0.42
KMT2A Q03164 1/20 0.42
PPARG P37231 1/20 0.41
NCOA2 Q15596 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2231482 0.89 ANXA2 (0.58) ANXA2S100A10ALDH1A1CCR1MEN1
SCHEMBL2232974 0.87 ANXA2 (0.65) ANXA2S100A10ALDH1A1
SCHEMBL2236163 0.86 ANXA2 (0.66) ANXA2S100A10ALDH1A1CCR1MEN1
SCHEMBL2236328 0.85 ALDH1A1 (0.66) ANXA2S100A10ALDH1A1MAPTCCR1
SCHEMBL2235286 0.83 ANXA2 (0.67) ANXA2S100A10ALDH1A1CCR1MEN1
SCHEMBL2230926 0.81 ANXA2 (0.66) ANXA2S100A10ALDH1A1CCR1MEN1
SCHEMBL2233884 0.80 ANXA2 (0.67) ANXA2S100A10ALDH1A1CCR1MEN1
SCHEMBL2233246 0.80 CCR1 (0.59) ANXA2S100A10ALDH1A1MAPTCCR1
SCHEMBL2299703 0.79 ANXA2 (0.70) ANXA2S100A10ALDH1A1CCR1MEN1
SCHEMBL2234993 0.78 ANXA2 (0.65) ANXA2S100A10ALDH1A1CCR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011092505-A1 S100 PROTEIN BINDING INTERACTION INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2011-08-04 WO claimed
WO-2011092505-A1 S100 PROTEIN BINDING INTERACTION INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2011-08-04 WO disclosed